Comorbidity Between Attention Deficit Hyperactivity Disorder... | Clinical Trial | StuddyBuddy@endsection Comorbidity Between Attention Deficit Hyperactivity Disorder and Fibromyalgia
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07443800

Comorbidity Between Attention Deficit Hyperactivity Disorder and Fibromyalgia

Conditions: ADHD - Attention Deficit Disorder With Hyperactivity, Fibromyalgia (FM), Chronic Pain

Sex: All
Ages: 18 Years – 100 Years
Healthy volunteers: No
Phase: NA
Enrollment: 100
Sponsor: University Hospital, Tours

Summary

The overall objective of the research project presented here is to assess the prevalence of fibromyalgia in patients being treated for ADHD, the prevalence of ADHD in patients being treated for fibromyalgia, and the neurobiological correlates of ADHD-fibromyalgia comorbidity.

Eligibility Criteria

Inclusion Criteria: For patients with fibromyalgia : * Men or women aged 18 or over * Diagnosis of fibromyalgia * Affiliated with a social security scheme * Having signed an informed consent form For patients with ADHD treated with methylphenidate * Men or women aged 18 or over * ADHD diagnosis * Current treatment with extended-release methylphenidate for at least 1 month, with stable dosage for at least 2 weeks * Affiliated with a social security scheme * Having signed an informed consent form For patients with ADHD but not treated with methylphenidate * Men or women aged 18 or over * ADHD diagnosis * Affiliated with a social security scheme * Having signed an informed consent form Exclusion Criteria: * For patients with fibromyalgia: existence of another condition explaining chronic pain * Severe cognitive impairment * Difficulties in understanding self-administered questionnaires * Difficulties in assessing pain intensity * Acute psychiatric disorder impacting the validity of self-report questionnaire data collection * Inability to take biological samples * Persons covered by Articles L1121-5 to L1121-8 of the CSP (corresponding to all protected persons: pregnant women, women in labor, nursing mothers, persons deprived of their liberty by judicial or administrative decision, minors, persons subject to legal protection measures: guardianship or curatorship).

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07443800). StuddyBuddy aggregates publicly available trial information.